CLINICAL_TRIALS
trial_result
· 2014-06-12
Clinical Trial Update: Tamoxifen and Bortezomib to Treat Recurrent Brain Tumors [Phase 2]
Summary
A Phase 2 trial evaluating the combination of tamoxifen and bortezomib for recurrent glioma has completed, with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Cancer Institute (NCI) | Conditions: Glioma | Phase 2 | Status: COMPLETED | Results posted: 2014-06-12